These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 11888361)

  • 1. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: The Disability in Strategies for Care (DISC) Study.
    Sculpher M; Millson D; Meddis D; Poole L
    Pharmacoeconomics; 2002; 20(2):91-100. PubMed ID: 11888361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost effectiveness of stratified care in the management of migraine.
    Williams P; Dowson AJ; Rapoport AM; Sawyer J
    Pharmacoeconomics; 2001; 19(8):819-29. PubMed ID: 11596834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: A randomized trial.
    Lipton RB; Stewart WF; Stone AM; Láinez MJ; Sawyer JP;
    JAMA; 2000 Nov 22-29; 284(20):2599-605. PubMed ID: 11086366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
    McCormack PL; Foster RH
    Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An economic evaluation of rizatriptan in the treatment of migraine.
    Thompson M; Gawel M; Desjardins B; Ferko N; Grima D
    Pharmacoeconomics; 2005; 23(8):837-50. PubMed ID: 16097844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the 'Act when Mild' study.
    Slof J
    Appl Health Econ Health Policy; 2012 May; 10(3):201-15. PubMed ID: 22320449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
    MacGregor EA; Brandes J; Eikermann A
    Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolmitriptan: a review of its use in migraine.
    Spencer CM; Gunasekara NS; Hills C
    Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
    Williams P; Reeder CE
    Clin Ther; 2003 Nov; 25(11):2903-19. PubMed ID: 14693315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolmitriptan nasal spray: advances in migraine treatment.
    Syrett N; Abu-Shakra S; Yates R
    Neurology; 2003 Oct; 61(8 Suppl 4):S27-30. PubMed ID: 14581655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
    Zhang L; Hay JW
    CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache.
    Mauskop A; Farkkila M; Hering-Hanit R; Rapoport A; Warner J
    Curr Med Res Opin; 1999; 15(4):282-9. PubMed ID: 10640260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of eletriptan in reducing time loss caused by migraine attacks.
    Wells NE; Steiner TJ
    Pharmacoeconomics; 2000 Dec; 18(6):557-66. PubMed ID: 11227394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.